Ian Terayma, left, program manager of Pacific Resource Partnership’s Partners in Democracy program; Max Rodriquez, a graduate of the past class; City Council member Matt Meyer, a fellow participant ...

CBSE Class 10 Board Exam Pattern 2025-26: The Central Board of Secondary Education (CBSE) has released the tentative exam schedule for Class 10 Board Exams 2026, which are set to begin from 17th ...

CBSE Class 10th Datesheet 2026- The Central Board of Secondary Education (CBSE) has officially released the much-anticipated date sheet for the Class 10 board examinations in 2026. This crucial ...

TUCSON, Ariz. – As artificial intelligence becomes more mainstream, the Pima County Sheriff’s Department is looking at how it can use the emerging technology. At the beginning of the year, deputies ...

(L-R) Millie Bobby Brown and Rachel Brosnahan Getty, Mei Tao EXCLUSIVE: Millie Bobby Brown (Stranger Things, Enola Holmes) will star in and executive produce the new series Prism, currently in ...

Avatar Legends: The Fighting Game is a fighter rooted in the spirit of elemental mastery. Designed for both newcomers and veterans, it channels the energy of classic fighting games while breaking new ...

EXCLUSIVE: 9/12, a six-episode limited series starring and executive produced by Emmy and Tony winner Jeremy Strong (Succession, Springsteen: Deliver Me from Nowhere), has been given an official green ...

-Redefining Allergy Treatment with New Class of Trifunctional ECRIs designed to deliver powerful efficacy, rapid relief and complete control of allergic responses by targeting the effector cell - ...

TORONTO – Julio Rodriguez and Jorge Polanco hit three-run homers and Canadian Josh Naylor added a two-run shot to power the Seattle Mariners to a 10-3 win over the Toronto Blue Jays in Game 2 of the ...

As the government shutdown stretches into day 14, funding for vital programs remains stuck in a deadlock limbo between Congressional Republicans and Democrats. Thus far, programs such as Social ...

PALO ALTO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Excellergy, a biotechnology company developing a new class of allergy therapeutics, today announced its launch with a $70 million Series A ...